Kazia Therapeutics Limited (NASDAQ:KZIA) changes shares on Tuesday trading session, with a change of -0.77% or -$0.03 shares. The trading starts at $3.96 and closed at $3.91 throughout the day. The trading session low price was $3.8201 and day high was $3.96 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 24612.0 while its average volume is 70.00K. In other hand, the KZIA market cap reached to $37.13M.
On June 22, 2020, BRIEF-Kazia Presents Further Paxalisib And Cantrixil Data At Aacr, Reinforcing Positive Efficacy Signals For Both Drugs. According to the news reported on Reuters, * KAZIA PRESENTS FURTHER PAXALISIB AND CANTRIXIL DATA AT AACR, REINFORCING POSITIVE EFFICACY SIGNALS FOR BOTH DRUGS
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -9.56% and up 12.46% for month. Its quarterly performance was 45.86% above, while its half year performance is down -6.23%. KZIA yearly performance stood at positive 33.79% and fall -10.60% for year-to-date.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. KZIA EPS (TTM) for 12-month is -1.29. It has an EPS of 17.70% up for past five years.
Let’s take a look on the analyst recommendations on KZIA for the current month and previous month. For the current month, 1 of 1 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $6.96 – $6.96. Average target price for KZIA was reached at $6.96.
Anson Funds Management LP, Transform Wealth, LLC and Morgan Stanley are the top three holders in Kazia Therapeutics Limited (KZIA) stock. On Mar 30, 2020, Anson Funds Management LP has 0.55 million shares which valued 1.59 million. On Jun 29, 2020, Transform Wealth, LLC owned 0.11 million shares which valued at 0.36 million. On Mar 30, 2020, Morgan Stanley has a total of 79303.0 shares which valued at 0.23 million. In the end, Morgan Stanley have 0.84% shares outstanding of Kazia Therapeutics Limited (KZIA) on Mar 30, 2020. The insider ownership moved to 28.80% and institutional holding shifted to 11.20%.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for KZIA rise 8.14% for period of 200 days. SMA for 50 days was 12.37% which is showing green signal, while SMA-20 was -1.00%. The moving average value for Kazia Therapeutics Limited (KZIA) is 462 and 0.18% for 200 and 50 days respectively.